🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT04881318
Recruiting Not applicable

Compression Garments in the Community With POTS

NCT04881318 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2021-05-17
Last updated
2026-05-07

Condition(s) studied

Postural Orthostatic Tachycardia Syndrome

Investigational drug(s) / intervention(s)

Waist-High Compression TightsAbdominal Compression GarmentsMedications that modulate heart rate and blood pressure

Waist-High Compression Tights: Waist-high compression tights providing 15-40 mmHg of pressure.

Abdominal Compression Garments: Abdominal compression garment compressing the abdomen, buttocks, and upper thighs.

Medications that modulate heart rate and blood pressure: Medications that modulate heart rate and blood pressure that participants regularly take. These medications include beta-blockers, midodrine, ivabradine and stimulants.

Study summary

Compression Garments are a commonly prescribed treatment in Postural Orthostatic Tachycardia Syndrome (POTS). The effectiveness of a proof-of-concept compression garment has been demonstrated in an acute laboratory setting. It is not known if commercially available compression garments that participants wear in their every day lives are effective at improving heart rate and reducing symptoms in POTS. This trial will evaluate the use of commercially available waist-high and abdominal compression garments in adults diagnosed with POTS in a community setting.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Physician diagnosis of Postural Tachycardia Syndrome (POTS) * Resident of Canada * Owns waist-high compression garment: medical grade or commercially available tights with a pressure rating provided (e.g. 15-18 mmHg, 20-30 mmHg, 30-40 mmHg) * Optional Sub-Study: owns an abdominal compression garment (e.g. abdominal shapewear, waist high shorts) * Able to participate in a 4-day study (2x2 day segments with a 5-day washout period) Exclusion Criteria: * Overt cause for postural tachycardia (i.e., acute dehydration, thyroid disease) that precludes POTS diagnosis * Not a resident of Canada * Participants with somatization or severe anxiety symptoms will be excluded * Pregnant (self-reported) * Inability to tolerate compression garments for the duration of the study * Does not own a waist-high compression garment * Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Calgary Calgary Alberta Recruiting

More University of Calgary trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04881318 on ClinicalTrials.gov ↗ ← All trials in Canada